Average Insider

Where insiders trade, we follow

Insider Buy/Sell Details for the Healthcare Sector — February 2026

Extreme outlier transactions (>3σ) are excluded.Show All Data
Ratio0.1:1
Daily Buy & Sell Volume

Pacira BioSciences, Inc. (PCRX)

WILLIAMS KRISTEN — Chief Administrative Officer
Feb 2, 2026
Sale
Shares
13,137
Price
$20.53
Total Value
$269.70K
Shares Held After
131,303
% of Holdings
9.1%

Biogen Inc. (BIIB)

Singhal Priya — Head of Development
Feb 2, 2026
Sale
Shares
748
Price
$179.30
Total Value
$134.12K
Shares Held After
6,271
% of Holdings
10.7%

BioAge Labs, Inc. (BIOA)

RUBIN PAUL D — Chief Medical Officer
Feb 2, 2026
Sale
Shares
7,433
Price
$18.75
Total Value
$139.37K
Shares Held After
0
% of Holdings
100.0%
Feb 2, 2026
Purchase
Shares
57,000
Price
$17.96
Total Value
$1.02M
Shares Held After
423,155
% of Holdings
13.5%

UNITED THERAPEUTICS Corp (UTHR)

BENKOWITZ MICHAEL — PRESIDENT AND COO
Feb 2, 2026
Sale
Shares
7,875
Price
$470.95
Total Value
$3.71M
Shares Held After
0
% of Holdings
100.0%

UNITED THERAPEUTICS Corp (UTHR)

BENKOWITZ MICHAEL — PRESIDENT AND COO
Feb 2, 2026
Sale
Shares
14,625
Price
$470.95
Total Value
$6.89M
Shares Held After
0
% of Holdings
100.0%

STRYKER CORP (SYK)

Pierce James Andrew — Group President
Feb 2, 2026
Sale
Shares
475
Price
$368.87
Total Value
$175.21K
Shares Held After
70,563
% of Holdings
0.7%
Feb 2, 2026
Sale
Shares
159,701
Price
$93.49
Total Value
$14.93M
Shares Held After
1,411,735
% of Holdings
10.2%
Feb 2, 2026
Sale
Shares
1,200
Price
$94.06
Total Value
$112.87K
Shares Held After
1,571,436
% of Holdings
0.1%

Inotiv, Inc. (NOTV)

Leasure Robert Jr. — Director
Feb 2, 2026
Sale
Shares
113,297
Price
$0.50
Total Value
$57.03K
Shares Held After
1,273,025
% of Holdings
8.2%

RESMED INC (RMD)

Sandercock Brett — Chief Financial Officer
Feb 2, 2026
Sale
Shares
1,000
Price
$257.03
Total Value
$257.03K
Shares Held After
85,495
% of Holdings
1.2%

Serina Therapeutics, Inc. (SER)

Moreadith Randall — Chief Scientific Officer
Feb 2, 2026
Sale
Shares
6,500
Price
$3.03
Total Value
$19.68K
Shares Held After
0
% of Holdings
100.0%
Feb 2, 2026
Sale
Shares
22,000
Price
$7.71
Total Value
$169.67K
Shares Held After
1,144,391
% of Holdings
1.9%

Ultragenyx Pharmaceutical Inc. (RARE)

Horn Howard — Chief Financial Officer
Feb 2, 2026
Sale
Shares
3,061
Price
$23.56
Total Value
$72.12K
Shares Held After
88,935
% of Holdings
3.3%

Alkermes plc. (ALKS)

Cooke Shane — Director
Feb 2, 2026
Sale
Shares
32,113
Price
$34.78
Total Value
$1.12M
Shares Held After
103,744
% of Holdings
23.6%

Alkermes plc. (ALKS)

Cooke Shane — Director
Feb 2, 2026
Sale
Shares
29,087
Price
$34.34
Total Value
$998.80K
Shares Held After
135,857
% of Holdings
17.6%

Alkermes plc. (ALKS)

Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Feb 2, 2026
Sale
Shares
4,000
Price
$33.54
Total Value
$134.16K
Shares Held After
57,740
% of Holdings
6.5%

Alkermes plc. (ALKS)

Hopkinson Craig C. — EVP R&D, Chief Medical Officer
Feb 2, 2026
Sale
Shares
5,000
Price
$34.24
Total Value
$171.22K
Shares Held After
61,740
% of Holdings
7.5%

Solid Biosciences Inc. (SLDB)

Herzich Paul — Chief Technology Officer
Feb 2, 2026
Sale
Shares
26,250
Price
$6.44
Total Value
$168.97K
Shares Held After
79,972
% of Holdings
24.7%

Solid Biosciences Inc. (SLDB)

Howton David T — Chief Operating Officer
Feb 2, 2026
Sale
Shares
37,771
Price
$6.44
Total Value
$243.13K
Shares Held After
116,753
% of Holdings
24.4%

Solid Biosciences Inc. (SLDB)

Hanrahan Jessie — Chief Regulatory Officer
Feb 2, 2026
Sale
Shares
26,535
Price
$6.44
Total Value
$170.80K
Shares Held After
82,675
% of Holdings
24.3%

Solid Biosciences Inc. (SLDB)

Brooks Gabriel — Chief Medical Officer
Feb 2, 2026
Sale
Shares
28,335
Price
$6.44
Total Value
$182.39K
Shares Held After
96,708
% of Holdings
22.7%
Feb 2, 2026
Sale
Shares
80,258
Price
$6.44
Total Value
$516.61K
Shares Held After
270,931
% of Holdings
22.9%

Solid Biosciences Inc. (SLDB)

Tan Kevin — CFO & Treasurer
Feb 2, 2026
Sale
Shares
26,837
Price
$6.44
Total Value
$172.75K
Shares Held After
108,984
% of Holdings
19.8%
Feb 2, 2026
Sale
Shares
32,410
Price
$185.60
Total Value
$6.02M
Shares Held After
7,229
% of Holdings
81.8%
Feb 2, 2026
Sale
Shares
16,284
Price
$5.09
Total Value
$82.90K
Shares Held After
63,456
% of Holdings
20.4%
Feb 2, 2026
Sale
Shares
14,814
Price
$5.09
Total Value
$75.41K
Shares Held After
167,935
% of Holdings
8.1%

Xeris Biopharma Holdings, Inc. (XERS)

Hecht Beth — Chief Legal Officer and Corporate Secretary
Feb 2, 2026
Sale
Shares
16,667
Price
$7.45
Total Value
$124.15K
Shares Held After
1,243,174
% of Holdings
1.3%
Feb 2, 2026
Sale
Shares
10,349
Price
$7.76
Total Value
$80.31K
Shares Held After
98,477
% of Holdings
9.5%

InspireMD, Inc. (NSPR)

Gleason Shane Thomas — Chief Commercial Officer
Feb 2, 2026
Sale
Shares
2,000
Price
$1.60
Total Value
$3.21K
Shares Held After
1,139,177
% of Holdings
0.2%

Clene Inc. (CLNN)

Ugwumba Chidozie — 10% Owner
Feb 2, 2026
Sale
Shares
3,800
Price
$4.04
Total Value
$15.35K
Shares Held After
555,559
% of Holdings
0.7%
Feb 2, 2026
Sale
Shares
91,000
Price
$9.38
Total Value
$853.43K
Shares Held After
364,350
% of Holdings
20.0%
Feb 2, 2026
Sale
Shares
18,065
Price
$5.09
Total Value
$91.96K
Shares Held After
173,614
% of Holdings
9.4%
Feb 2, 2026
Sale
Shares
2,000
Price
$5.09
Total Value
$10.18K
Shares Held After
84,065
% of Holdings
2.3%
Feb 2, 2026
Purchase
Shares
24
Price
$10.00
Total Value
$239.99
Shares Held After
681
% of Holdings
3.5%

CYTOKINETICS INC (CYTK)

Callos Andrew — EVP, Chief Commercial Officer
Feb 2, 2026
Sale
Shares
886
Price
$62.10
Total Value
$55.02K
Shares Held After
50,440
% of Holdings
1.7%
Version: v26.3.33